Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . (ICCRN RCT2)
This study has been terminated.
( The major and primary reason for the study termination is the observed reduced efficacy of CellCept compared to placebo. )
Study NCT00451867 Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: March 23, 2007 Last Updated: June 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interstitial Cystitis
Painful Bladder Syndrome
Additional conditions recognized in this trial
Cystitis
Cystitis, Interstitial
Syndrome
More general conditions related to this trial
Disease
Pathologic Processes
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
Mycophenolate Mofetil
Mycofenolate Mofetil (MMF)
Placebo
Additional drug interventions recognized in this trial
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
